Author: Lizana, Ignacio; Uribe, Elena A.; Delgado, Eduardo J.
Title: A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2 Cord-id: p0wup2eo Document date: 2021_7_8
ID: p0wup2eo
Snippet: Klebsiella pneumoniae carbapenemase (KPC-2) is the most commonly encountered class A β-lactamase variant worldwide, which confer high-level resistance to most available antibiotics. In this article we address the issue by a combined approach involving molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics calculations. The study contributes to improve the understanding, at molecular level, of the acylation and deacylation stages of avibactam involved in the inhibition o
Document: Klebsiella pneumoniae carbapenemase (KPC-2) is the most commonly encountered class A β-lactamase variant worldwide, which confer high-level resistance to most available antibiotics. In this article we address the issue by a combined approach involving molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics calculations. The study contributes to improve the understanding, at molecular level, of the acylation and deacylation stages of avibactam involved in the inhibition of KPC-2. The results show that both mechanisms, acylation and deacylation, the reaction occur via the formation of a tetrahedral intermediate. The formation of this intermediate corresponds to the rate limiting stage. The activation barriers are 19.5 kcal/mol and 23.0 kcal/mol for the acylation and deacylation stages, respectively. The associated rate constants calculated, using the Eyring equation, are 1.2 × 10(−1) and 3.9 × 10(−4) (s(−1)). These values allow estimating a value of 3.3 × 10(−3) for the inhibition constant, in good agreement with the experimental value. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10822-021-00408-3.
Search related documents:
Co phrase search for related documents- active site and actually cause: 1
- active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- active site and acylation mechanism: 1
- active site and acylation reaction: 1, 2
- active site and long range: 1, 2, 3, 4, 5
- active site and lung infection: 1, 2
- actually cause and acute respiratory syndrome: 1
- acute respiratory syndrome and acylation mechanism: 1, 2
- acute respiratory syndrome and acylation reaction: 1
Co phrase search for related documents, hyperlinks ordered by date